This inventor holds 4 USPTO granted patents. Top assignees: Gambro Ab, Gambro Ag. Active years: 1978-1982.
Company Filing History:
Years Active: 1978-1982
Title: Innovations by Lars A Qvarnstrom
Introduction
Lars A Qvarnstrom is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of medical technology, particularly in the measurement of low-molecular weight compounds in complex fluids. With a total of four patents to his name, Qvarnstrom's work has the potential to impact various medical applications.
Latest Patents
One of his latest patents is a method for sampling and measuring the content of low-molecular weight compounds, such as glucose, cholesterol, or urea, in complex fluid mediums like blood. This innovative method involves placing a dialyzer in contact with the fluid medium, allowing it to pass through the dialyzer. Semipermeable membranes are used to create passageways for dialysis fluid, enabling the selective diffusion of low-molecular weight compounds into the dialysis fluid. The resulting dialysate is then measured to determine the concentration of the compound in the original fluid.
Another significant patent by Qvarnstrom is a method and apparatus for measuring the concentration of a compound in a liquid medium. This invention is particularly useful for assessing low molecular weight compounds in complex mediums. The process involves using a dialyzer to facilitate the diffusion of the compound into a dialysate, which is then treated with enzymes to convert the compound into a measurable reaction product. The concentration of this product is indicative of the original compound's content in the complex fluid.
Career Highlights
Throughout his career, Lars A Qvarnstrom has worked with prominent companies in the medical technology sector, including Gambro AB and Gambro AG. His experience in these organizations has contributed to his expertise in developing innovative solutions for medical diagnostics.
Collaborations
Qvarnstrom has collaborated with notable professionals in his field, including Ulf T Nylen and Bo H Hakansson. These collaborations have likely enriched his research and development efforts, leading to advancements in medical technology.
Conclusion
Lars A Qvarnstrom's contributions to the field of medical technology through his innovative patents demonstrate his commitment to improving diagnostic methods. His work continues to influence the way low-molecular weight compounds are measured in complex fluids, showcasing the importance of innovation in healthcare.